RIPK3 deficiency could ameliorate myocardial injury in mice with cardiac hypertrophy, improve cardiac function, inhibit CaMKII activation, correct the CaMKII δ alternative splicing disorder, and reduce necrosis. Here, RIPK3 is linked to cardiac hypertrophy.